Collaborations & PartnershipsGlobalNF1NF2-SWNPress ReleaseSWN ANNOUNCING THE LAUNCH OF CHILDREN’S TUMOR FOUNDATION EUROPE
GlobalNF1Science & Research Selumetinib Granted Orphan Drug Designation by the European Medicines Agency
NF1Science & Research NF1 Clinical Trial of Selumetinib “Most Exciting” Says National Cancer Institute Director
